Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. Company
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Nanoform Finland Oyj is a Finland-based limited liability Company offering services in nanotechnology and drug particle engineering for the international pharma industry. The Company’s affairs consist of both internal research and development activities and proof of concept type of research and development services provided to customers.

Number of employees : 74 people.
Sales per Business
20192020Delta
Nanotechnology and Drug Particle Engineering0.05100%0.69100% +1298.87%
EUR in Million
Sales per region
2020
Europe0.5579.6%
United States0.1420.4%
EUR in Million
Managers
Name Title Age Since
Edward Hæggström, Dr. Chief Executive Officer 51 2015
Albert Alexander Hæggström Chief Financial Officer & Director 49 2018
Niklas Sandler, Dr. Chief Technology Officer 48 2019
Gonçalo Nuno N. da Silva Rebelo de Andrade Chief Business Operations - 2019
Miguel Maria de Oliveira Barreiros Calado Chairman 64 2020
Mads Laustsen Vice Chairman 63 2020
Henri von Haartman Director-Investor Relations - 2019
David Rowe, Dr. Head-Manufacturing 53 2019
Christian Jones Chief Commercial Officer - 2018
Peter Hänninen General Counsel - 2020
Members of the board
Name Title Age Since
Miguel Maria de Oliveira Barreiros Calado Chairman 64 2020
Albert Alexander Hæggström Chief Financial Officer & Director 49 2018
Mads Laustsen Vice Chairman 63 2020
Cynthia S. Schwalm Director 60 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 72,535,146 49,351,729 68.0% 0 0.0% 68.0%
Shareholders
NameEquities%
Mandatum Henkivakuutusosakeyhtiö Oy 5,854,590 8.09%
Helsingin Yliopiston Rahastot 5,489,640 7.59%
Edward Hæggström 5,409,405 7.48%
Handelsbanken Fonder AB 4,722,954 6.53%
DNB Asset Management AS 3,518,749 4.86%
Keskinäinen Eläkevakuutusyhtiö Ilmarinen 3,114,000 4.30%
Fjärde AP-fonden 2,898,550 4.01%
Jouko Yliruusi 2,700,000 3.73%
Kai Falck 2,700,000 3.73%
Avohoidon Tutkimussäätiö sr 2,638,737 3.65%
Company contact information
Nanoform Finland Oyj
Cultivator II
Viikinkaari 4
Helsinki, Uusimaa 00790

Phone : +358.29.3700150
Web : http://www.nanoform.fi
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
NANOFORM FINLAND OYJ-1.13%607
JOHNSON & JOHNSON8.01%432 430
ROCHE HOLDING AG11.02%325 975
PFIZER, INC.12.66%218 198
ELI LILLY AND COMPANY41.25%209 276
NOVARTIS AG0.20%207 246
ABBVIE INC.9.70%199 548
MERCK & CO., INC.-6.44%195 475
NOVO NORDISK A/S31.37%188 446
ASTRAZENECA PLC15.50%155 197
BRISTOL-MYERS SQUIBB COMPANY9.56%149 020
AMGEN INC.6.45%139 433
SANOFI11.22%131 827
GLAXOSMITHKLINE PLC5.04%98 364
JIANGSU HENGRUI MEDICINE CO., LTD.-33.80%67 158
CHUGAI PHARMACEUTICAL CO., LTD.-25.00%65 930
ALLERGAN PLC0.97%63 659
BAYER AG6.18%60 766
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.20%53 101
DAIICHI SANKYO COMPANY, LIMITED-37.04%42 298
ASTELLAS PHARMA INC.19.95%33 619